Our approach to precision medicine is to provide robust, comprehensive, clinically actionable information to help guide treatment options for your patients. The disease targeted panels will aid in navigating within standard of care and clinical trial treatment options. Our broader, 50SEQ®, will include both standard of care and outside standard of care treatment options.
We know that traditional treatment options may become exhausted in patients who have failed therapies or suffer from rare cancers. Using Next Generation Sequencing, we can determine molecular changes in a tumor specific to an individual which may identify targeted therapies or clinical trials to inform of additional treatment decisions.
The US Oncology Network and Texas Oncology Dedicated Hotline: 1.972.966.7050 or 1.877.966.7050